Apovac F.M.B.A.
Company details
- CVR number
- 40504044
- Status
- Active
- Legal form
- Forening med begrænset ansvar
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler(464610)
- Founded
- 1 April 2019
- Address
- Smørmosevej 16C, 2880 Bagsværd
- Municipality
- Gladsaxe
Find similar companies in the same industry and build a lead list right inside your AI.
Key figures
The latest 3 financial years from the annual reports. Amounts in Danish kroner (DKK).
| Financial year | 2025 | 2024 | 2022/23 |
|---|---|---|---|
| Gross profit | DKK 3.4m | DKK 3.0m | DKK 2.0m |
| Net profit | −DKK 694k | −DKK 146k | −DKK 1.7m |
| Equity | DKK 11.5m | DKK 12.2m | DKK 3.4m |
| Employees (avg.) | 3 | 3 | 4 |
Track the trend via the API.REST API (OpenAPI)
Get all 6 years of financials right inside Claude or ChatGPT via MCP.
Similar companies
Other active companies in Engroshandel med medicinalvarer og sygeplejeartikler in Gladsaxe, close in size (employees and gross profit).
- MCNEIL DENMARK ApS
2860 Søborg
17 employees · gross profit DKK 33.0m (2025)
- CONVATEC DENMARK A/S
2860 Søborg
15 employees · gross profit DKK 20.1m (2025)
- ALMIRALL ApS
2860 Søborg
11 employees · gross profit DKK 17.4m (2025)
- SPECIALBANDAGER.DK A/S
2880 Bagsværd
9 employees · gross profit DKK 11.8m (2025)
- APEX PHARMA ApS
2860 Søborg
1 employee · gross profit -DKK 215k (2025)
- Novozymes Biopharma DK A/S
2880 Bagsværd
gross profit DKK 17.7m (2025)
- Novo Nordisk Health Care AG
2880 Bagsværd
- Baxter Healthcare SA
2860 Søborg
See all:Engroshandel med medicinalvarer og sygeplejeartikler (553)Gladsaxe (5,753)
Full financials and history
Lead Strategist is free during the beta with 20,000 credits a month. Get every figure for this company right inside your AI or via the API.
- All 6 financial years in the database
- Balance sheet: assets, liabilities, provisions and cash
- EBIT, gross profit and reporting class
- Auditor and audit firm
Free beta · 20,000 credits a month · no card
By creating an account you accept the terms on behalf of your business.